Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06246396
PHASE4

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

Sponsor: University of Florida

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn about the mechanisms by which minocycline effect blood pressure in individuals with treatment-resistant hypertension. The main questions it aims to answer are: * To what extent does minocycline lower blood pressure? * Are such blood pressure effects mediated through changes in gut microbiota, gut leakiness, systemic inflammation, neuroinflammation, or some combination of these? Participants will be randomly assigned to treatment with minocycline or placebo, treated daily for 3 months, to evaluate these questions.

Official title: Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the Gut Microbiota-brain-immune Axis

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-01-08

Completion Date

2028-07

Last Updated

2026-03-06

Healthy Volunteers

No

Interventions

DRUG

Minocycline Hydrochloride

Minocycline Hydrochloride 100 mg twice daily

DRUG

Placebo

Placebo

Locations (1)

UF Clinical Research Center (UF CRC) - CTSI

Gainesville, Florida, United States